Showing results (81-90 of 275) with videos related to
Sort By:
Pageof 28
Plos One|September 25, 2020
Mantle cell lymphoma with gastrointestinal involvement and the role of endoscopic examinationsHan Hee Lee, Seok-Goo Cho, In Seok Lee, et al.Arthritis and Rheumatism|March 9, 2011
Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesisMin-Jung Park, Hyun-Sil Park, Mi-La Cho, et al.World Journal of Stem Cells|October 9, 2020
Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanismsYunejin Song, Jung-Yeon Lim, Taekyu Lim, et al.Experimental & Molecular Medicine|May 24, 2012
B cell-associated immune profiles in patients with end-stage renal disease (ESRD)Kyoung Woon Kim, Byung Ha Chung, Eun Joo Jeon, et al.Radiation Oncology Journal|December 30, 2016
Analysis of treatment outcomes for primary tonsillar lymphomaYun Hee Lee, Seok Goo Cho, Seung Eun Jung, et al.Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Protective effect of irradiated renal carcinoma expressing hepatitis B surface antigen against renal-cell carcinoma-mediated tumorsYuseok Moon, Seok Goo Cho, Jong Wook Lee, et al.Cancers|September 27, 2025
Survival Machine Learning Methods Improve Prediction of Histologic Transformation in Follicular and Marginal Zone LymphomasTong-Yoon Kim, Tae-Jung Kim, Eun Ji Han, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2025
Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial StudyRaeseok Lee, Nayoun Kim, Won-Bok Kim, et al.Annals of Hematology|February 22, 2011
Clinical outcomes of post-remission therapy using (90)yttrium ibritumomab tiuxetan (Zevalin®) for high-risk patients with diffuse large B-cell lymphomaEun Ji Han, Sung-Eun Lee, Sung Hoon Kim, et al.International Journal of Molecular Sciences|June 27, 2024
Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical StudyNayoun Kim, Gi-June Min, Keon-Il Im, et al.Pageof 28